Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could monthly texts and automatic risk scores stop heart attacks before they start?

NCT ID NCT05919056

NEW Prevention Sponsor: Peking University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing whether primary care clinics can prevent heart attacks and strokes by automatically calculating each patient's cardiovascular risk and sending monthly text messages with advice to those at high risk. The trial enrolls about 22,000 adults aged 40 to 79 in Yinzhou, China, who have no history of heart disease, stroke, or heart failure but whose 10-year risk score is 10% or higher. Clinics are randomly assigned to use the risk-based monitoring strategy or usual care, and researchers will track changes in risk factors like blood pressure and cholesterol, as well as whether fewer participants have major cardiovascular events.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
automatic cardiovascular risk scoring with monthly text-message advice
What this could lead to
If it works, this could give primary care clinics a low-cost way to flag high-risk patients and nudge them toward prevention before a heart attack or stroke happens.
What could go wrong
The strategy relies on patients acting on text messages and on clinics using the risk scores. Many prevention trials show that reminding people does not always change long-term outcomes, and the study may not prove that this approach prevents heart attacks or strokes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 22,032 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2023

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 79 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Residents in the Yinzhou District have a unique health ID; * Aged 40 to 79 years at the baseline enrollment; * With high risk of cardiovascular disease evaluated by the 2019 WHO laboratory-based risk models (10-year risk≥10%); Exclusion Criteria: * Have a history of coronary heart disease, stroke or heart failure; * Patients with a diagnosis of cancer; * Refused to provide written informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder prevention target heart failure prevention target stroke disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Yinzhou District Center for Disease Control and Prevention

    RECRUITING

    Ningbo, Zhejiang, 315100, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.